Experimental benchmarking of in silico annotations at prostate cancer risk loci and hypothesis-generating cross-cancer prioritisation of ovarian risk variants
Genome-wide association studies (GWAS) have identified numerous non-coding risk variants for prostate and ovarian cancers, yet determining which are regulatorily active and which target genes they control remains challenging. We re-analysed a dinucleotide-barcode massively parallel reporter assay (DiR-seq) of 208 bi-al...